Biology of Aging

Brocklehurst's Textbook of Geriatric Medicine and Gerontology

Volumn , Issue , 2010, Pages 30-37

  Warner, Huber R ^a   Sierra, Felipe ^b   Thompson, LaDora V ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874600044     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6231-8.10006-6     Document Type: Chapter

References (118)

1. Miller R.A. Kleemeier Award lecture: Are there genes for aging?. J Gerontol 1999, 54A:B297-B307.
2. McCay C.M., Crowell M.F., Maynard L.A. The effect of retarded growth upon the length of life span and upon ultimate body size. J Nutr 1935, 10:63-75.
3. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956, 2:298-300.
4. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965, 37:614-636.
5. Couzin J. How much can human life span be extended?. Science 2005, 309:83.
6. Modern biological theories of aging 1987, Raven Press, New York. H.R. Warner, R.N. Butler, R.L. Sprott (Eds.).
7. Hart R.W., Setlow R.B. Correlation between deoxyribonucleic acid excision repair and life-span in a number of mammalian species. Proc Natl Acad Sci USA 1974, 71:2169-2173.
8. Monnier V.M. Nonenzymatic glycosylation, the Maillard reaction and the aging process. J Gerontol 1990, 45:B105-B111.
9. Beckman K.B., Ames B.N. The free radical theory of aging matures. Physiol Rev 1998, 78:547-581.
10. Han ES, Muller FL, Perez V, et al: The in vivo expression signature of oxidative stress. Physiol Genomics 2008;(in press).
11. Luckinbill L.S., Clare M.J. Successful selection for increased longevity in Drosophila: analysis of the survival data and presentation of a hypothesis on the genetic regulation of longevity. Exp Gerontol 1987, 22:221-226.
12. Friedman D.B., Johnson T.E. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics 1988, 118:75-86.
13. Kenyon C., Chang J., Gensch E., et al. A C. elegans mutant that lives twice as long as wild type. Nature 1993, 366:461-464.
14. Dorman J.B., Albinder B., Shroyer T., et al. The age-1 and daf-2 genes function in a common pathway to control the lifespan of Caenorhabditis elegans. Genetics 1995, 141:1399-1406.
15. Larsen P.L., Albert P.S., Riddle D.L. Genes that regulate both development and longevity in Caenorhabditis elegans. Genetics 1995, 139:1567-1583.
16. Brown-Borg H.M., Borg K.E., Meliska C.J., et al. Dwarf mice and the ageing process. Nature 1996, 384:33.
17. Flurkey K., Papaconstantinou J., Harrison D.E. The Snell dwarf mutation Pit1(dw) can increase life span in mice. Mech Ageing Dev 2002, 123:121-130.
18. Coschigano K.T., Holland A.N., Riders M.E., et al. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 2003, 144:3799-3810.
19. Holzenberger M., Dupont J., Ducos B., et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003, 421:182-187.
20. Taguchi A., Wartschow L.M., White M.F. Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 2007, 317:369-372.
21. Selman C., Lingard S., Choudhury A.I., et al. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J 2008, 22:807-818.
22. Conover C.A., Bale L.K. Loss of pregnancy-associated plasma protein A extends lifespan in mice. Aging Cell 2007, 6:727-729.
23. Sherlock M., Toogood A.A. Aging and the growth hormone/insulin like growth factor-I axis. Pituitary 2007, 10:189-203.
24. Suh Y., Atzmon G., Cho M.D., et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci USA 2008, 105:3438-3442.
25. Wolff S., Dillin A. The trifecta of aging in Caenorhabditis elegans. Exp Gerontol 2006, 41:894-903.
26. Henderson S.T., Johnson T.E. Daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr Biol 2001, 11:1975-1980.
27. Salih D.A., Brunet A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol 2008, 20:126-136.
28. Murphy C.T. The search for DAF-16/FOXO transcriptional targets: approaches and discoveries. Exp Gerontol 2006, 41:910-921.
29. Lin K., Hsin H., Libina N., et al. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat Genet 2001, 28:139-145.
30. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
31. Blackburn E.H., Greider C.W., Henderson E., et al. Recognition of and elongation of telomeres by telomerase. Genome 1989, 31:553-560.
32. Bodnar A.G., Ouellette M., Frolkis M., et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349-352.
33. Blasco M.A. Telomere length, stem cells and aging. Nat Chem Biol 2007, 3:640-649.
34. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120:513-522.
35. Krtolica A., Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol 2002, 34:1401-1414.
36. Feldser D.M., Greider C.W. Short telomeres limit tumor progression in vivo by inducing senescence. Cancer Cell 2007, 11:461-469.
37. Sedivy J.M. Telomeres limit cancer growth by inducing senescence: long-sought in vivo evidence obtained. Cancer Cell 2007, 11:389-391.
38. Dimri G.P., Lee X., Basile G., et al. A novel biomarker identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995, 92:9363-9367.
39. Wright W.E., Piatyszek M.A., Rainey W.E., et al. Telomerase activity in germline and embryonic tissues and cells. Dev Genet 1996, 18:173-179.
40. Weng N.P., Levine B.L., June C.H., et al. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996, 183:2471-2479.
41. Kim N.W., Piatyszek M.A., Prowse K.R., et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
42. Shay J.W., Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997, 33:787-791.
43. Walne A.J., Dokal I. Dyskeratosis congenita: A historical perspective. Mech Ageing Dev 2008, 129:48-59.
44. Collins K. Physiological assembly and activity of human telomere complexes 2008, 129:91-98.
45. Sharpless N.E., DePinho R.A. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 2007, 8:703-713.
46. Rudolph K.L., Chang S., Lee H-W., et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999, 96:701-712.
47. Kudlow B.A., Kennedy B.K., Monnat R.J. Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases. Nat Rev Mol Cell Biol 2007, 8:394-404.
48. Cawthon R.M., Smith K.R., O'Brien E., et al. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003, 361:393-395.
49. Panossian L.A., Porter V.R., Valenzuela H.F., et al. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging 2003, 24:77-84.
50. Epel E.S., Blackburn E.H., Lin J., et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 2004, 101:17312-17315.
51. Ogami M., Ikura Y., Ohsawa M., et al. Telomere shortening in human coronary artery diseases. Arterioscler Thromb Vasc Biol 2004, 24:546-550.
52. Njajou O.T., Cawthon R.M., Damcott C.M., et al. Telomere length is paternally inherited and is associated with parental lifespan. Proc Natl Acad Sci USA 2007, 104:12135-12139.
53. Shawi M., Autexier C. Telomerase, senescence and ageing. Mech Ageing Dev 2008, 129:3-10.
54. Migliaccio E., Giorgio M., Mele S., et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999, 402:309-313.
55. Ruzankina Y., Pinzon-Guzman C., Asare A., et al. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 2007, 1:113-126.
56. Weissman I.L. Stem cells: units of development, units of regeneration, and units in evolution. Cell 2000, 100:157-168.
57. Rossi D.J., Bryder D., Zahn J.M., et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci USA 2005, 102:9194-9199.
58. Conboy I.M., Conboy M.J., Wagers A.J., et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 433:760-764.
59. Nishimura E.K., Granter S.R., Fisher D.E. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science 2005, 307:720-724.
60. INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006, 443:453-457.
61. Rossi D.J., Bryder D., Seita J., et al. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007, 447:725-730.
62. Warner H.R. 2006 Kent Award lecture: is cell death and replacement a factor in aging?. J Gerontol 2007, 62A:1228-1232.
63. Warner H.R. Is cell death and replacement a factor in aging?. Mech Ageing Dev 2007, 128:13-16.
64. Tyner S.D., Venkatachalam S., Choi J., et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002, 415:45-53.
65. Dumble M., Moore L., Chambers S.M., et al. The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood 2007, 109:1736-1742.
66. Allsop R.C., Marin G.B., DePinho R., et al. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 2003, 102:517-520.
67. Warner H.R., Sierra F. Models of accelerated aging can be informative about the molecular mechanisms of ageing and/or age-related pathology. Mech Ageing Dev 2003, 124:581-587.
68. Halaschek-Wiener J., Brooks-Wilson A. Progeria of stem cells: stem cell exhaustion in Hutchinson-Gilford progeria syndrome. J Gerontol 2007, 62A:3-8.
69. Baumgartner R.N., Koehler K.M., Gallagher D., et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998, 147:755-763.
70. Roubenoff R. Sarcopenia and its implications for the elderly. Eur J Clin Nutr 2000, 54:S40-S47.
71. Janssen I., Shepard D.S., Katzmarzyk P.T., et al. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 2004, 52:80-85.
72. Sohal R.S., Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996, 273:59-63.
73. Ostdal H., Skibsted L.H., Andersen H.J. Formation of long-lived protein radicals in the reaction between H2O2-activated metmyoglobin and other proteins. Free Radic Biol Med 1997, 23:754-761.
74. Zhong S., Lowe D.A., Thompson L.V. Effects of hindlimb unweighting and aging on rat semimembranosus muscle and myosin. J Appl Physiol 2006, 101:873-880.
75. Lowe D.A., Surek J.T., Thomas D.D., et al. Electron paramagnetic resonance reveals age-related myosin structural changes in rat skeletal muscle fibers. Am J Physiol Cell Physiol 2001, 280:C540-C547.
76. Thompson L.V., Brown M. Age-related changes in contractile properties of single skeletal fibers from the soleus muscle. J Appl Physiol 1999, 86:881-886.
77. Stadtman E.R., Berlett B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol 1997, 10:485-494.
78. Andrade F.H., Reid M.B., Allen D.G., et al. Effect of nitric oxide on single skeletal muscle fibres from the mouse. J Physiol 1998, 509(pt 2):577-586.
79. Callahan L.A., She Z.W., Nosek T.M. Superoxide, hydroxyl radical, and hydrogen peroxide effects on single-diaphragm fiber contractile apparatus. J Appl Physiol 2001, 90:45-54.
80. Lamb G.D., Posterino G.S. Effects of oxidation and reduction on contractile function in skeletal muscle fibres of the rat. J Physiol 2003, 546:149-163.
81. Mosoni L., Breuille D., Buffiere C., et al. Age-related changes in glutathione availability and skeletal muscle carbonyl content in healthy rats. Exp Gerontol 2004, 39:203-210.
82. Oh-Ishi M., Ueno T., Maeda T. Proteomic method detects oxidatively induced protein carbonyls in muscles of a diabetes model Otsuka Long-Evans Tokushima Fatty (OLETF) rat. Free Radic Biol Med 2003, 34:11-22.
83. Plant D.R., Lynch G.S., Williams D.A. Hydrogen peroxide modulates Ca2+-activation of single permeabilized fibres from fast- and slow-twitch skeletal muscles of rats. J Muscle Res Cell Motil 2000, 21:747-752.
84. Syrovy I., Hodny Z. Non-enzymatic glycosylation of myosin: effects of diabetes and ageing. Gen Physiol Biophys 1992, 11:301-307.
85. Viner R.I., Ferrington D.A., Williams T.D., et al. Protein modification during biological aging: selective tyrosine nitration of the SERCA2a isoform of the sarcoplasmic reticulum Ca2+-ATPase in skeletal muscle. Biochem J 1999, 340:657-669.
86. Thompson L.V., Durand D., Fugere N.A., et al. Myosin and actin expression and oxidation in aging muscle. J Appl Physiol 2006, 101:1581-1587.
87. Snow L.M., Fugere N.A., Thompson L.V. Advanced glycation end-product accumulation and associated protein modification in type II skeletal muscle with aging. J Gerontol 2007, 62A:1204-1210.
88. Prochniewicz E., Thomas D.D., Thompson L.V. Age-related decline in actomyosin function. J Gerontol 2005, 60A:425-431.
89. Viner R.I., Williams T.D., Schoneich C. Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase. Biochemistry 1999, 38:12408-12415.
90. Alvarez B., Radi R. Peroxynitrite reactivity with amino acids and proteins. Amino Acids 2003, 25:295-311.
91. Cassina A.M., Hodara R., Souza J.M., et al. Cytochrome c nitration by peroxynitrite. J Biol Chem 2000, 275:21409-21415.
92. Sharov V.S., Dremina E.S., Galeva N.A., et al. Quantitative mapping of oxidation-sensitive cysteine residues in SERCA in vivo and in vitro by HPLC-electrospray-tandem MS: selective protein oxidation during biological aging. Biochem J 2006, 394:605-615.
93. Balagopal P., Rooyackers O.E., Adey D.B., et al. Effects of aging on in vivo synthesis of skeletal muscle myosin heavy-chain and sarcoplasmic protein in humans. Am J Physiol 1997, 273:E790-E800.
94. Andrade F.H., Reid M.B., Allen D.G., et al. Effect of hydrogen peroxide and dithiothreitol on contractile function of single skeletal muscle fibres from the mouse. J Physiol 1998, 509:565-575.
95. Sell D.R., Monnier V.M. Structure elucidation of a senescence cross-link from human extracellular-matrix-implication of pentoses in the aging process. J Biol Chem 1989, 264:21597-21602.
96. Ferrington D.A., Husom A.D., Thompson L.V. Altered proteasome structure, function, and oxidation in aged muscle. FASEB J 2005, 19. 664-646.
97. Husom A.D., Peters E.A., Kolling E.A., et al. Altered proteasome function and subunit composition in aged muscle. Arch Biochem Biophys 2004, 421:67-76.
98. Brown SM, Smith DM, Alt N, et al: Tissue-specific variation in glycation of proteins in diabetes-evidence for a functional role of amadoriase enzymes. In Maillard Reaction: Chemistry at the Interface of Nutrition, Aging, and Disease, 2005.
99. Gomes R., Miranda H., Silva M., et al. Yeast protein glycation in vivo by methylglyoxal. FEBS J 2006, 273:5273-5287.
100. Ramamurthy B., Hook P., Jones A.D., et al. Changes in myosin structure and function in response to glycation. FASEB J 2001, 15:2415-2422.
101. Janssen I., Heymsfield S.B., Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002, 50:889-896.
102. Bean J.F., Kiely D.K., Herman S., et al. The relationship between leg power and physical performance in mobility-limited older people. J Am Geriatr Soc 2002, 50:461-467.
103. Bean J.F., Leveille S.G., Kiely D.K., et al. A comparison of leg power and leg strength within the InCHIANTI study: Which influences mobility more?. J Gerontol 2003, 58A:728-733.
104. Foldvari M., Clark M., Laviolette L.C., et al. Association of muscle power with functional status in community-dwelling elderly women. J Gerontol 2000, 55A:M192-M199.
105. Runge M., Rittweger J., Russo C.R., et al. Is muscle power output a key factor in the age- related decline in physical performance? A comparison of muscle cross section, chair-rising test and jumping power. Clin Physiol Funct Imaging 2004, 24:335-340.
106. Janssen I., Baumgartner R.N., Ross R., et al. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004, 159:413-421.
107. Visser M., Goodpaster B.H., Kritchevsky S.B., et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol 2005, 60A:324-333.
108. Metter E.J., Talbot L.A., Schrager M., et al. Arm-cranking muscle power and arm isometric muscle strength are independent predictors of all-cause mortality in men. J Appl Physiol 2004, 96:814-821.
109. Gruenberg E.M. The failures of success. Milbank Mem Fund Q 1977, 55:3-24.
110. Miniño A.M., Heron M.P., Murphy S.L., et al. Deaths: final data for 2004. Natl Vital Stat Rep 2007, 55(19):1-119.
111. Olshansky J., Carnes B.A., Cassel C. In search of Methuselah: estimating the upper limits to human longevity. Science 1990, 250:634-640.
112. Butler R.N., Warner H.R., Williams T.F., et al. The aging factor in health and disease: the promise of basic aging research, special report. Aging Clin Exp Res 2004, 16:104-112.
113. Olshansky S.J., Perry D., Miller R.A., et al. In pursuit of the longevity dividend. Scientist 2006, 20:28-36.
114. Olshansky S.J., Perry D., Miller R.A., et al. Pursuing the longevity dividend. Scientific goals for an aging world. Ann NY Acad Sci 2007, 1114:11-13.
115. Miller R.A. Extending life: scientific prospects and political obstacles. Milbank Q 2002, 80:155-174.
116. Delaying the onset of late-life dysfunction 1995, Springer Publishing, New York. R.N. Butler, J.A. Brody (Eds.).
117. Herndon L.A., Schmeissner P.J., Dudaronek J.M., et al. Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature 2002, 419:808-814.
118. Berzlanovich A.M., Keil W., Waldhoer T., et al. Do centenarians die healthy? An autopsy study. J Gerontol 2005, 60A:862-865.